<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2024 (8) TMI 1722 - CESTAT BANGLORE</title>
    <link>https://www.taxtmi.com/caselaws?id=468419</link>
    <description>SSI exemption under Notification No. 8/2003-CE was unavailable where veterinary medicaments were manufactured on loan licence basis in the same factory using the same infrastructure, because aggregate clearances had to be tested at the factory level and the threshold had already been crossed. The duty demand was therefore sustained. The extended period of limitation was invocable because the assessees did not disclose the material fact that exemption was being claimed despite factory-level turnover exceeding the limit, amounting to suppression of facts. Penalties were upheld against the appellant units, reduced for M/s. Makam Pharmachem, and not sustained against individual partners or directors absent specific evidence of their role.</description>
    <language>en-us</language>
    <pubDate>Mon, 05 Aug 2024 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 05 May 2026 18:36:10 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=900036" rel="self" type="application/rss+xml"/>
    <item>
      <title>2024 (8) TMI 1722 - CESTAT BANGLORE</title>
      <link>https://www.taxtmi.com/caselaws?id=468419</link>
      <description>SSI exemption under Notification No. 8/2003-CE was unavailable where veterinary medicaments were manufactured on loan licence basis in the same factory using the same infrastructure, because aggregate clearances had to be tested at the factory level and the threshold had already been crossed. The duty demand was therefore sustained. The extended period of limitation was invocable because the assessees did not disclose the material fact that exemption was being claimed despite factory-level turnover exceeding the limit, amounting to suppression of facts. Penalties were upheld against the appellant units, reduced for M/s. Makam Pharmachem, and not sustained against individual partners or directors absent specific evidence of their role.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Mon, 05 Aug 2024 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=468419</guid>
    </item>
  </channel>
</rss>